A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators report in a new pair of studies.
Click here for original story, Study unravels a cause of resistance to novel drug in patients with acute leukemia
Source: ScienceDaily